Literature DB >> 17591626

IKAP/hELP1 deficiency in the cerebrum of familial dysautonomia patients results in down regulation of genes involved in oligodendrocyte differentiation and in myelination.

David Cheishvili1, Channa Maayan, Yoav Smith, Gil Ast, Aharon Razin.   

Abstract

The gene affected in the congenital neuropathy familial dysautonomia (FD) is IKBKAP that codes for the IKAP/hELP1 protein. Several different functions have been suggested for this protein, but none of them have been verified in vivo or shown to have some link with the FD phenotype. In an attempt to elucidate the involvement of IKAP/hELP1 in brain function, we searched for IKAP/hELP1 target genes associated with neuronal function. In a microarray expression analysis using RNA extracted from the cerebrum of two FD patients as well as sex and age matched controls, no genes were found to be upregulated in the FD cerebrum. However, 25 genes were downregulated more than 2-fold in the cerebrum of both the male FD child and female FD mature woman. Thirteen of them are known to be involved in oligodendrocyte development and myelin formation. The down regulation of all these genes was verified by real-time PCR. Four of these genes were also confirmed to be downregulated at the protein level. These results are statistically significant and have high biological relevance, since seven of the downregulated genes in the cerebrum of the FD patients were shown by others to be upregulated during oligodendrocyte differentiation in vitro. Our results therefore suggest that IKAP/hELP1 may play a role in oligodendrocyte differentiation and/or myelin formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591626     DOI: 10.1093/hmg/ddm157

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  27 in total

Review 1.  Mechanisms of disease in hereditary sensory and autonomic neuropathies.

Authors:  Annelies Rotthier; Jonathan Baets; Vincent Timmerman; Katrien Janssens
Journal:  Nat Rev Neurol       Date:  2012-01-24       Impact factor: 42.937

2.  IKAP/hELP1 down-regulation in neuroblastoma cells causes enhanced cell adhesion mediated by contactin overexpression.

Authors:  Rachel Cohen-Kupiec; Shiri Weinstein; Gal Kantor; Dan Peer; Miguel Weil
Journal:  Cell Adh Migr       Date:  2010 Oct-Dec       Impact factor: 3.405

3.  IKAP/Elp1 is required in vivo for neurogenesis and neuronal survival, but not for neural crest migration.

Authors:  Barbara J Hunnicutt; Marta Chaverra; Lynn George; Frances Lefcort
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

Review 4.  Axon Transport and Neuropathy: Relevant Perspectives on the Etiopathogenesis of Familial Dysautonomia.

Authors:  Warren G Tourtellotte
Journal:  Am J Pathol       Date:  2015-12-24       Impact factor: 4.307

5.  Retrograde nerve growth factor signaling abnormalities in familial dysautonomia.

Authors:  Lin Li; Katherine Gruner; Warren G Tourtellotte
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 6.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

7.  Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes.

Authors:  Darja Kanduc
Journal:  Biologics       Date:  2010-09-13

8.  Neuroimaging supports central pathology in familial dysautonomia.

Authors:  Felicia B Axelrod; Max J Hilz; Dena Berlin; Po Lai Yau; David Javier; Victoria Sweat; Hannah Bruehl; Antonio Convit
Journal:  J Neurol       Date:  2009-08-25       Impact factor: 4.849

9.  Tocotrienol Treatment in Familial Dysautonomia: Open-Label Pilot Study.

Authors:  David Cheishvili; Channa Maayan; Naama Holzer; Jeanna Tsenter; Elad Lax; Sophie Petropoulos; Aharon Razin
Journal:  J Mol Neurosci       Date:  2016-04-30       Impact factor: 3.444

10.  Loss-of-function of IKAP/ELP1: could neuronal migration defect underlie familial dysautonomia?

Authors:  Tiina Naumanen; Lars D Johansen; Eleanor T Coffey; Tuula Kallunki
Journal:  Cell Adh Migr       Date:  2008-10-17       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.